Talk to us

Adobe and the SAFE-BioPharma Association

Partnering to streamline identity management

The SAFE-BioPharma Association is revolutionizing the information lifecycle in life sciences. Its efforts are supported by the Pharmaceutical Research and Manufacturers Association and major pharmaceutical companies seeking to streamline identity management. The SAFE-BioPharma Association is transforming electronic document processing by addressing the standards, legal policies, and technologies necessary to help ensure document authenticity. Life sciences companies joining the association and adopting the Secure Access for Everyone (SAFE) standards for digital signatures can reduce time to market and the cost of clinical trials.

Adobe's support for the SAFE digital signature standards allows life sciences companies to reduce costly paper-based business processes involved in developing a new drug. Using Adobe solutions, SAFE members can streamline the movement of authenticated information across lines of business, between headquarters and clinical investigators, and among companies and government regulators.

Adobe solutions provide persistent document security capabilities that:

Reduce costs by eliminating the dependence on paper, printing, document storage, and transport costs
Save time by making it easy to find and distribute the correct documents to accelerate clinical trials
Improve integrity and authentication by verifying the source of a document and determining whether it has been altered
Simplify the process of protecting sensitive information with document controls, digital signature support, and document certification services
Meet compliance requirements by providing an auditable electronic document of record
Eliminate record redundancies by compiling multiple documents and forms into a single Adobe® PDF file.

866.485.2999 (sales)
877.469.3627 (support)

Adobe and the SAFE-BioPharma Association Solution Brief (PDF, 623 KB)
SAFE white paper (PDF, 160 KB)
Adobe Electronic Forms for Clinical Development Solution Brief (PDF, 655 KB)
The SAFE-BioPharma Association (website link)